Advanced Centre for Treatment Research & Education in Cancer

Science Sparks @ ACTREC
31 August 2026	Vol. No. 15 ; Issue No.750

Publications

1. Zeineldin M, Murry JB, Shetty D, Middlezong W, Parish R, Xiao Z, Cui C, Li P, Wen J, Tang G, Zou YS (2026). Acquired ring chromosomes in hematological malignancies: A systematic evidence review for diagnostic advances, cytogenomic insights, and clinical significance by an International Consortium on Human Ring Chromosomes (ICHRC) working group. Cancer Genetics.306-307:69-90

2. Mohanty P, Madaan P, Patkar N, Shetty D (2026). Myeloid/lymphoid neoplasm with FLT3 rearrangement. Journal of Hematology and Allied Sciences. 6:179-81.

3. Krishnamurthy A, Shridhar K, Mehrotra R, Pimple S, Shashidhara LS, Dhup S, Vijayakumar M (2026). Cancer research in India: Proceedings of an expert consensus panel. Indian Journal of Cancer.

4. Noronha V, Menon N, Shah M, Patil V, Dhanawat A, Prakash G, Pal M, Arora A, Misra A, Goud S, More S, Yadav A, Murthy V, Maitre P, Menon S, Popat P, Sable N, Agarwal A, Rangarajan V, Shetake A, Badwe R, Prabhash K (2026). Randomized trial of adjuvant 5-FU-platinum vs paclitaxel-platinum for high-risk penile cancer. Journal of National Cancer Institute.

5. Mirian C, Jensen LR....Young JS, Magill ST, Bertero L... Gupta T, Patel AJ, Klisch TJ Kim JW...etal (2026). Variation in meningioma recurrence risk estimates across observational cohorts: the influence of calendar time, WHO classifications, geographical settings, and healthcare systems. Journal of Neurooncology.179(2):60.

Site of the Week

The Genotype-Tissue Expression (GTEx) Portal is a comprehensive public resource for researchers studying tissue and cell-specific gene expression and regulation across individuals and development, and species, with data from 3 NIH projects.

Interesting Reads

Franceschini GM, Georgakopoulou K, Ciriello G, Oricchio E. Origins and consequences of oncogenic 3D chromatin remodelling. Nature Reviews Cancer.

Video of the Week

Service, Education and Research with Dr Shripad Banavali

Upcoming Events

Workshop on Cancer Epidemiology and Public Health

September 3-5, 2026

At ACTREC, Tata Memorial Centre, Kharghar , Navi Mumbai

Workshop On Cell Line Generation & CME on Tumor Microenvironment

October 8-10, 2026

At ACTREC, Tata Memorial Centre, Kharghr, Navi Mumbai

Cytogenomic Microarray Workshop

October 26-29, 2026

At ACTREC, Tata Memorial Centre, Kharghar, Navi Mumbai

Do You Know?

In 2004, FDA approved bevacizumab, a monoclonal antibody targeting vascular endothelial growth factor, for the treatment of advanced colorectal cancer. This was the first approval of an antiangiogenic agent to treat cancer

Cancer News

FDA approves daraxonrasib for metastatic pancreatic cancer following landmark clinical trial led by Dana-Farber.

EurekAlert, 26/08/2026

Daraxonrasib is the first approved targeted therapy in pancreatic cancer designed to inhibit RAS, the major cancer-driving pathway in the disease. It works as a molecular glue that together with another protein, cyclophilin A, blocks the signaling of RAS proteins...

Supercharged “natural killer” cells could be a powerful new cancer weapon

Sciencedaily, 25/08/2026

Researchers have found a way to supercharge natural killer cells, powerful immune cells that can attack cancer, so they can penetrate solid tumors and keep fighting once inside. In mice, these specially prepared tissue-resident cells slowed the growth of several tumors, including melanoma and head ....

New discovery helps identify colorectal cancer patients at risk for metastasis.

News-Medical, 25/08/2026

The researchers studied mucinous colorectal adenocarcinoma, an aggressive form of cancer that constitutes for around 10-15 percent of all colorectal cancers. It is more common in young adults and women. Unlike most colorectal cancers, mucinous colorectal adenocarcinoma spreads in the form of...

2026 Advanced Centre for Treatment, Research and Education in Cancer (ACTREC)